<?xml version="1.0" encoding="UTF-8"?><safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>JP-MLMSERVICE-TESTCASE-20150427-42</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20150213</transmissiondate>
		<reporttype>1</reporttype>
		<serious>1</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>20150204</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>20150204</receiptdate>
		<additionaldocument>2</additionaldocument>
		<documentlist/>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<authoritynumb/>
		<companynumb>JP-MLMSERVICE-TESTCASE-20150427-42</companynumb>
		<duplicate>1</duplicate>
		<casenullification/>
		<nullificationreason/>
		<medicallyconfirm/>
		<reportduplicate>
			<duplicatesource/>
			<duplicatenumb>201502658</duplicatenumb>
		</reportduplicate>
		<primarysource>
			<reportertitle/>
			<reportergivename>Sayaka</reportergivename>
			<reportermiddlename/>
			<reporterfamilyname>Takahashi</reporterfamilyname>
			<reporterorganization>Yamanashi Prefectural Central Hospital</reporterorganization>
			<reporterdepartment/>
			<reporterstreet/>
			<reportercity/>
			<reporterstate>Yamanashi</reporterstate>
			<reporterpostcode/>
			<reportercountry>JP</reportercountry>
			<qualification>2</qualification>
			<literaturereference>Takahashi S. An Effort for Proposal of Prescription and Efforts to Solve Problems by a Pharmacist in a Nutrition Support Team (NST). J Jpn Soc Parenter Enteral Nutr. 2015;30(1):510</literaturereference>
			<studyname/>
			<sponsorstudynumb/>
			<observestudytype/>
		</primarysource>
		<sender>
			<sendertype>6</sendertype>
			<senderorganization>MLMSERVICE</senderorganization>
			<senderdepartment>test</senderdepartment>
			<sendertitle>dr</sendertitle>
			<sendergivename>mlmtest</sendergivename>
			<sendermiddlename/>
			<senderfamilyname>test</senderfamilyname>
			<senderstreetaddress>test</senderstreetaddress>
			<sendercity>test</sendercity>
			<senderstate/>
			<senderpostcode>1</senderpostcode>
			<sendercountrycode>GB</sendercountrycode>
			<sendertel>12345</sendertel>
			<sendertelextension>3456</sendertelextension>
			<sendertelcountrycode>44</sendertelcountrycode>
			<senderfax>12345</senderfax>
			<senderfaxextension>3456</senderfaxextension>
			<senderfaxcountrycode>44</senderfaxcountrycode>
			<senderemailaddress>1@MLMSERVICE.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype/>
			<receiverorganization>EVTEST</receiverorganization>
			<receiverdepartment/>
			<receivertitle/>
			<receivergivename/>
			<receivermiddlename/>
			<receiverfamilyname/>
			<receiverstreetaddress/>
			<receivercity/>
			<receiverstate/>
			<receiverpostcode/>
			<receivercountrycode/>
			<receivertel/>
			<receivertelextension/>
			<receivertelcountrycode/>
			<receiverfax/>
			<receiverfaxextension/>
			<receiverfaxcountrycode/>
			<receiveremailaddress/>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientgpmedicalrecordnumb/>
			<patientspecialistrecordnumb/>
			<patienthospitalrecordnumb/>
			<patientinvestigationnumb/>
			<patientbirthdateformat/>
			<patientbirthdate/>
			<patientonsetage>73</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<gestationperiod/>
			<gestationperiodunit/>
			<patientagegroup/>
			<patientweight/>
			<patientheight/>
			<patientsex>1</patientsex>
			<lastmenstrualdateformat/>
			<patientlastmenstrualdate/>
			<patientmedicalhistorytext>The patient's other history of illicit drug use/drug abuse, alcohol use and smoking was not reported.</patientmedicalhistorytext>
			<resultstestsprocedures/>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>17.1</patientepisodenamemeddraversion>
				<patientepisodename>10038444</patientepisodename>
				<patientmedicalstartdateformat/>
				<patientmedicalstartdate/>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalenddateformat/>
				<patientmedicalenddate/>
				<patientmedicalcomment>for 30 years</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>17.1</patientepisodenamemeddraversion>
				<patientepisodename>10017758</patientepisodename>
				<patientmedicalstartdateformat/>
				<patientmedicalstartdate/>
				<patientmedicalcontinue/>
				<patientmedicalenddateformat/>
				<patientmedicalenddate/>
				<patientmedicalcomment/>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>17.1</patientepisodenamemeddraversion>
				<patientepisodename>10061965</patientepisodename>
				<patientmedicalstartdateformat/>
				<patientmedicalstartdate/>
				<patientmedicalcontinue/>
				<patientmedicalenddateformat/>
				<patientmedicalenddate/>
				<patientmedicalcomment/>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>17.1</patientepisodenamemeddraversion>
				<patientepisodename>10061105</patientepisodename>
				<patientmedicalstartdateformat/>
				<patientmedicalstartdate/>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalenddateformat/>
				<patientmedicalenddate/>
				<patientmedicalcomment/>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>INAPPETENCE</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10054792</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>4</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>6</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>TRAMCET</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugbatchnumb/>
				<drugauthorizationnumb>GB Mkt</drugauthorizationnumb>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugauthorizationholder>Non-Gruenenthal</drugauthorizationholder>
				<drugstructuredosagenumb/>
				<drugstructuredosageunit/>
				<drugseparatedosagenumb/>
				<drugintervaldosageunitnumb/>
				<drugintervaldosagedefinition/>
				<drugcumulativedosagenumb/>
				<drugcumulativedosageunit/>
				<drugdosagetext>UNK</drugdosagetext>
				<drugdosageform>Film-coated tablet</drugdosageform>
				<drugadministrationroute>48</drugadministrationroute>
				<drugparadministration/>
				<reactiongestationperiod/>
				<reactiongestationperiodunit/>
				<drugindicationmeddraversion>17.1</drugindicationmeddraversion>
				<drugindication>10070592</drugindication>
				<drugstartdateformat/>
				<drugstartdate/>
				<drugstartperiod/>
				<drugstartperiodunit/>
				<druglastperiod/>
				<druglastperiodunit/>
				<drugenddateformat/>
				<drugenddate/>
				<drugtreatmentduration/>
				<drugtreatmentdurationunit/>
				<actiondrug>5</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<drugadditional/>
				<activesubstance>
					<activesubstancename>PARACETAMOL</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>TRAMADOL HYDROCHLORIDE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10054792</drugreactionasses>
					<drugassessmentsource>GRUNENTHAL</drugassessmentsource>
					<drugassessmentmethod>GLOBAL INTROSPECTION</drugassessmentmethod>
					<drugresult>Possible</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10054792</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>GLOBAL INTROSPECTION</drugassessmentmethod>
					<drugresult>Possible</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>NAUZELIN</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugbatchnumb/>
				<drugauthorizationnumb/>
				<drugauthorizationcountry/>
				<drugauthorizationholder/>
				<drugstructuredosagenumb/>
				<drugstructuredosageunit/>
				<drugseparatedosagenumb/>
				<drugintervaldosageunitnumb/>
				<drugintervaldosagedefinition/>
				<drugcumulativedosagenumb/>
				<drugcumulativedosageunit/>
				<drugdosagetext>UNK</drugdosagetext>
				<drugdosageform>Tablet</drugdosageform>
				<drugadministrationroute>48</drugadministrationroute>
				<drugparadministration/>
				<reactiongestationperiod/>
				<reactiongestationperiodunit/>
				<drugindicationmeddraversion>17.1</drugindicationmeddraversion>
				<drugindication>10070592</drugindication>
				<drugstartdateformat/>
				<drugstartdate/>
				<drugstartperiod/>
				<drugstartperiodunit/>
				<druglastperiod/>
				<druglastperiodunit/>
				<drugenddateformat/>
				<drugenddate/>
				<drugtreatmentduration/>
				<drugtreatmentdurationunit/>
				<actiondrug>5</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<drugadditional>Reported drug name: Nauzelin OD</drugadditional>
				<activesubstance>
					<activesubstancename>DOMPERIDONE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>Manufacturer Control Number: 2015-11000This spontaneous literature case from Japan was reported by a pharmacist via license partner and was initially received on 04-Feb-2015. It concerns a 73-year-old male patient (height and weight unknown).The patient's medical history and concurrent conditions included renal failure chronic, gastric cancer, gastrectomy and dialysis. The patient's other history of illicit drug use/drug abuse, alcohol use and smoking was not reported.The patient was treated with tramadol hydrochloride, paracetamol (Tramcet, film-coated tablet, oral) initiated on an unspecified date (posology unknown) for unknown indication.Other suspected medication included domperidone (Nauzelin, tablet, oral)  initiated on an unspecified date (posology unknown) for unknown indication.No relevant concomitant medication was reported.On an unspecified date, the patient experienced decreased appetite.It was reported that the patient had been undergoing dialysis for chronic renal failure for 30 years, until the time of this report.On an unspecified date, the patient was hospitalized for pleural effusion retention, dyspnoea and inappetence. The reporter thought that the continuous administration of an analgesic drug such as tramadol/apap tablet and an adverse drug reaction to an antiemetic drug, domperidone orodispersible tablet, were the causes of the event inappetence. The reporter stated that a proposal was made to reduce the doses of tramadol/apap and domperidone. Action taken with tramadol/apap and domperidone was not reported.The patient's outcome was not reported for the event inappetence.The reporter stated that the event of inappetence was related to the suspect drug tramadol/apap and domperidone.No relevant laboratory data were reported.No treatment of the AE was reported.No further information was available.Literature citation:takahashi s. an effort for proposal of prescription and efforts to solve problems by a pharmacist in a nutrition support team (nst). j jpn soc parenter enteral nutr. 2015; 30(1): 510***Third party case numbers:e2b company number: jp-jnjfoc-20150206714e2b report duplicate: 201502658</narrativeincludeclinical>
				<reportercomment/>
				<senderdiagnosismeddraversion/>
				<senderdiagnosis/>
				<sendercomment>Decreased appetite is assessed as serious.Decreased appetite is listed in the Company Core Datasheet of tramadol hydrochloride, paracetamol (oral).Decreased appetite is assessed to be possibly related to the administration of tramadol hydrochloride, paracetamol.The information in this single case does not appear to alter the favorable benefit to risk ratio of tramadol hydrochloride, paracetamol.Time to onset was not provided, but the sequence of events suggests a plausible temporal relationship. Appetite disorders belong to the known reactions for tramadol hydrochloride, paracetamol and are thus assessed to be possibly related to its administration, in the absence of alternative explanations.</sendercomment>
			</summary>
		</patient>
	</safetyreport>